Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug;35(4):631-644.
doi: 10.1007/s10334-022-01013-7. Epub 2022 May 17.

Ultra-high-field MR in Prostate cancer: Feasibility and Potential

Affiliations
Review

Ultra-high-field MR in Prostate cancer: Feasibility and Potential

Carlijn J A Tenbergen et al. MAGMA. 2022 Aug.

Abstract

Multiparametric MRI of the prostate at clinical magnetic field strengths (1.5/3 Tesla) has emerged as a reliable noninvasive imaging modality for identifying clinically significant cancer, enabling selective sampling of high-risk regions with MRI-targeted biopsies, and enabling minimally invasive focal treatment options. With increased sensitivity and spectral resolution, ultra-high-field (UHF) MRI (≥ 7 Tesla) holds the promise of imaging and spectroscopy of the prostate with unprecedented detail. However, exploiting the advantages of ultra-high magnetic field is challenging due to inhomogeneity of the radiofrequency field and high local specific absorption rates, raising local heating in the body as a safety concern. In this work, we review various coil designs and acquisition strategies to overcome these challenges and demonstrate the potential of UHF MRI in anatomical, functional and metabolic imaging of the prostate and pelvic lymph nodes. When difficulties with power deposition of many refocusing pulses are overcome and the full potential of metabolic spectroscopic imaging is used, UHF MR(S)I may aid in a better understanding of the development and progression of local prostate cancer. Together with large field-of-view and low-flip-angle anatomical 3D imaging, 7 T MRI can be used in its full strength to characterize different tumor stages and help explain the onset and spatial distribution of metastatic spread.

Keywords: Lymph nodes; Metabolic imaging; Prostate cancer; Ultra-high-field (UHF) MRI; mpMRI.

PubMed Disclaimer

Conflict of interest statement

The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Figures

Fig. 1
Fig. 1
T2w imaging of the prostate in two orientations. Axial (a, b) and sagittal (c, d) slices of the prostate of a patient with prostate cancer at 3 T (a, c) and at 7 T (b, d). The patient had a Gleason 3 + 4 lesion in the right midgland peripheral zone. The 3 T data was acquired with an endorectal coil (Medrad®, Pittsburgh, PA, US) at a spatial resolution of 0.4 × 0.4 × 3.0 mm (TE 101 ms, acquisition time 4:21 min for each orientation). 7 T data was acquired as in [35] with an external 8-channel transceiver coil after phase shimming at a spatial resolution of 0.75 × 0.75 × 3.0 mm (TE 71 ms, acquisition time 1:30 min for each orientation)
Fig. 2
Fig. 2
MRI with an ERC at 7 T of the prostate of a 62-year-old patient with prostate cancer (Gleason score 3 + 3). a Five transversal T2w turbo spin-echo images from a series of 23 slices from apex to seminal vesicles, resolution 0.3 × 0.3 × 2.0 mm3. b Transversal ADC maps at corresponding locations (5 images from 23 slices), resolution 1.75 × 1.75 × 2.0 mm3. Reprinted with permission from Lagemaat et al. [41]
Fig. 3
Fig. 3
GPC + GPE and PC + PE, metabolite maps of a 67-year-old patient with metastatic Gleason 4 + 4 prostate cancer (a, b) overlaid over a T2w image. 31P (c, d) spectra are shown of the cancer lesion (red circle) as well as a location within healthy tissue (blue circle). Adapted from Philips et al. [56]
Fig. 4
Fig. 4
The effect of USPIO nanoparticles at 7 T in the lymph nodes of a 54-year old patient with prostate cancer metastases. ac Sagittal images of the same location at different computed echo times (TEs). d Lipid-selective image. e The original TE = 8.3 ms image from the multigradient echo water-selective imaging. f Map of fitted R2* relaxation rates. g Sagittal overview image with inset of location of images af. Three lymph nodes accumulated USPIO particles and rapidly lost MR signal intensity (white circles), while one suspicious lymph node without USPIOs retained MR signal intensity with increasing TE (white arrow). The lymph node marked with (#) showed a slow signal decay, with an R2* value of 80 ± 6 s−1, whereas the lymph node marked with (*) showed fast signal decay, with an R2* value of 247 ± 25 s−1. Reprinted with permission from Scheenen et al. [64]
Fig. 5
Fig. 5
Full FOV and zoomed-in versions of axial and coronal T2w TSE images of prostates from 4 subjects. Images demonstrate excellent contrast and SNR achieved by phase-only RF shimming. Although providing high peak B1+ and reasonable homogeneity over the prostate, the local RF shim resulted in unmanaged RF fields outside the immediate region of the targeted anatomy that caused spatially varying destructive interference patterns as observed in the unzoomed images. Reprinted with permission from He et al. [69]

References

    1. Hegde JV, Mulkern RV, Panych LP, Fennessy FM, Fedorov A, Maier SE, Tempany CMC. Multiparametric MRI of prostate cancer: An update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging. 2013;37:1035–1054. doi: 10.1002/jmri.23860. - DOI - PMC - PubMed
    1. Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, Rouviere O, Logager V, Futterer JJ. ESUR prostate MR guidelines 2012. Eur Radiol. 2012;22(4):746–757. doi: 10.1007/s00330-011-2377-y. - DOI - PMC - PubMed
    1. de Rooij M, Hamoen EH, Witjes JA, Barentsz JO, Rovers MM. Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis. Eur Urol. 2016;70(2):233–245. doi: 10.1016/j.eururo.2015.07.029. - DOI - PubMed
    1. Drost FH, Osses D, Nieboer D, Bangma CH, Steyerberg EW, Roobol MJ, Schoots IG. Prostate magnetic resonance imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a cochrane systematic review and meta-analysis. Eur Urol. 2020;77(1):78–94. doi: 10.1016/j.eururo.2019.06.023. - DOI - PubMed
    1. Witherspoon L, Breau RH, Lavallée LT. Evidence-based approach to active surveillance of prostate cancer. World J Urol. 2020;38:555–562. doi: 10.1007/s00345-019-02662-5. - DOI - PubMed

LinkOut - more resources